Clinical Trial Update: Acamprosate in the Treatment of Binge-Eating Disorder [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on completed Phase 2 and Phase 3 studies evaluating acamprosate for binge eating disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder

Drugs mentioned

• acamprosate (acamprosate)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Binge Eating Disorder | Phase 2, Phase 3 | Status: COMPLETED